Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisone

M Weiss; P Maslak; E Feldman; E Berman; J Bertino; T Gee; L Megherian; K Seiter; D Scheinberg; D Golde

doi:10.1200/JCO.1996.14.9.2480

Back

Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisone

Journal article

Peer reviewed

Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisone

M Weiss, P Maslak, E Feldman, E Berman, J Bertino, T Gee, L Megherian, K Seiter, D Scheinberg and D Golde

Journal of clinical oncology, Vol.14(9), pp.2480-2485

1996

DOI: https://doi.org/10.1200/JCO.1996.14.9.2480

PMID: 8823326

Abstract

Biological and medical sciences

Medical sciences

Pharmacology. Drug treatments

Antineoplastic Agents

Chemotherapy

Metrics

8 Record Views

54 Times Cited - Web of Science

Details

Title: Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisone
Creators: M Weiss - Division of Hematologic Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center and Cornell University Medical College, New York, United States
P Maslak - Division of Hematologic Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center and Cornell University Medical College, New York, United States
E Feldman - Division of Hematologic Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center and Cornell University Medical College, New York, United States
E Berman - Division of Hematologic Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center and Cornell University Medical College, New York, United States
J Bertino - Division of Hematologic Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center and Cornell University Medical College, New York, United States
T Gee - Division of Hematologic Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center and Cornell University Medical College, New York, United States
L Megherian - Division of Hematologic Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center and Cornell University Medical College, New York, United States
K Seiter - Division of Hematologic Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center and Cornell University Medical College, New York, United States
D Scheinberg - Division of Hematologic Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center and Cornell University Medical College, New York, United States
D Golde - Division of Hematologic Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center and Cornell University Medical College, New York, United States
Publication Details: Journal of clinical oncology, Vol.14(9), pp.2480-2485
Date published: 1996
Publisher: Lippincott Williams & Wilkins
Academic Unit: Bertino Office
Language: English
Resource Type: Journal article
Identifiers: 991031665659704646